News from the healthcare data industry
Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise software and...
New Executive Appointments Bolster Komodo’s Seasoned Leadership Team as It Exceeds $200M in Annual Recurring Revenue in Fiscal Year 2023, Signaling Continued Business Momentum Vikas Mehta, Chief Financial Officer, Komodo...
World’s Leading Life Sciences, Academic, and Government Research Teams Leverage Komodo’s Healthcare Map™ to Gain Deeper, More Nuanced Understanding of Real-World Patient Journeys May 08, 2023 11:00 AM Eastern Daylight...
Platform Model Changes the Paradigm for Health Data Utilization, Unlocking Deeper Insights Spanning Health Claims, Genomics, Clinical Encounters, Labs, and Costs SAN FRANCISCO, APRIL 26 – Komodo Health today unveils...
Komodo’s Healthcare Map and Technology Platform Are Increasingly Utilized to Close Gaps in Colorectal Cancer Screening; Research Collaboration Under Way With CDC March 10, 2023 08:00 AM Eastern Standard Time...
Integrated Measurement Delivers Actionable, Privacy-Safe Patient Insights for Real-Time Planning, Activation, and Optimization NEW YORK, Feb. 27, 2023 /PRNewswire/ — PulsePoint, a technology company revolutionizing health decision-making in real time, today announced...
Komodo’s technology and clinical insights are helping support patients across more than 20 conditions spanning oncology, chronic illness, and rare disease February 14, 2023 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS...
Giles Bruce – Wednesday, December 14th, 2022 Data analytics company Komodo Health has laid off 9 percent of its staff in an effort to run a “capital efficient business,” its founders posted on LinkedIn....
Health data startup Komodo Health secured a structured equity infusion of $200 million in early November as it looks to continue scaling its data-driven “healthcare map” and analytics tools. Coatue...
Over the past few years, life sciences commercial teams quickly adapted to the impact Covid had on everything from meetings and engagement to launches and patient adherence. Looking forward, how can one apply their learnings to...